Key facts
- Developer of a three-dimensional cell culture platform designed to support precision medicine and drug development.
- It has raised $35.0M; the latest was Later Stage VC ($13.9M) in Mar 2026.
- Notable investors include Samsung Venture Investment, Mirae Asset Capital, Shinhan Venture Investment, Korea Technology Finance, K2 Investment Partners — 17 tracked in total.
- Status: Privately Held (backing).
Free account
More of Medical & Bio Decision with a free account
- ·The complete investor list: 17 names
- ·Watch Medical & Bio Decision: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for Medical & Bio Decision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About Medical & Bio Decision
Developer of a three-dimensional cell culture platform designed to support precision medicine and drug development. The company offers bioengineered cell culture systems and research technologies, enabling pharmaceutical companies and research institutions to study disease mechanisms and improve therapeutic development.
- Sector
- Healthcare
- HQ
- Suwon, South Korea
- Founded
- 2015
- Employees
- 45
- Website
- mbdbiotech.com/
- Ownership
- Privately Held (backing)
Valuation — not yet priced
Medical & Bio Decision doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.